What Researchers Did
Researchers investigated the immunomodulating effect of hyperbaric oxygenation (HBO) on the immune status of patients with corneal allotransplantation experiencing rejection, by analyzing peripheral blood lymphocyte phenotypes.
What They Found
Hyperbaric oxygenation (HBO) did not show an immunodepressive effect, as evidenced by no significant changes in lymphocyte subpopulations (CD3+, CD4+, CD8+, CD16+, CD56+) or activation markers (CD25, HLA-DR) in either patients or donors. Despite the lack of direct immunomodulation, HBO demonstrated a positive clinical effect in patients with corneal allotransplantation.
What This Means for Canadian Patients
For Canadian patients undergoing corneal allotransplantation and experiencing rejection, hyperbaric oxygenation (HBO) might offer a beneficial adjunctive therapy. This could potentially improve outcomes and reduce complications associated with graft-versus-host reactions in these patients.
Canadian Relevance
This study was not conducted in Canada and has no direct Canadian connection.
Study Limitations
The study did not fully elucidate the direct mechanism by which hyperbaric oxygenation exerts its positive clinical effect, suggesting an indirect pathway.